Last reviewed · How we verify

Vitamin B12B

General Oncology, Inc. · Phase 1 active Small molecule

Vitamin B12B is a Small molecule drug developed by General Oncology, Inc.. It is currently in Phase 1 development. Also known as: Hydroxocobalamin.

At a glance

Generic nameVitamin B12B
Also known asHydroxocobalamin
SponsorGeneral Oncology, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Vitamin B12B

What is Vitamin B12B?

Vitamin B12B is a Small molecule drug developed by General Oncology, Inc..

Who makes Vitamin B12B?

Vitamin B12B is developed by General Oncology, Inc. (see full General Oncology, Inc. pipeline at /company/general-oncology-inc).

Is Vitamin B12B also known as anything else?

Vitamin B12B is also known as Hydroxocobalamin.

What development phase is Vitamin B12B in?

Vitamin B12B is in Phase 1.

Related